Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators.

[1]  L. Erhardt,et al.  Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group. , 1995, European heart journal.

[2]  J. Kostis,et al.  Fosinopril: Pharmacokinetics and pharmacodynamics in congestive heart failure , 1995, Clinical pharmacology and therapeutics.

[3]  D. Stott,et al.  Effects of captopril and enalapril on renal function in elderly patients with chronic heart failure. , 1995, Postgraduate medical journal.

[4]  E. J. Brown,et al.  Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. Fosinopril Heart Failure Study Group. , 1995, The American journal of cardiology.

[5]  F. Zannad,et al.  Comparison of treatment with lisinopril versus enalapril for congestive heart failure. , 1992, The American journal of cardiology.

[6]  D. Sica.  Kinetics of Angiotensin-Converting Enzyme Inhibitors in Renal Failure , 1992, Journal of cardiovascular pharmacology.

[7]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[8]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[9]  D. Willard,et al.  Pharmacokinetics, Safety, and Pharmacologic Effects of Fosinopril Sodium, an Angiotensin‐Converting Enzyme Inhibitor in Healthy Subjects , 1991, Journal of clinical pharmacology.

[10]  K. Duchin.  Clinical Pharmacology of Fosinopril , 1991 .

[11]  K. Kripalani,et al.  Review of the Pharmacokinetics of Fosinopril in Special Populations , 1991 .

[12]  F. Wang,et al.  Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs. , 1989, American Journal of Hypertension.

[13]  G. Francis,et al.  Long-term effects of a once-a-day versus twice-a-day regimen of enalapril for congestive heart failure. , 1989, The American journal of cardiology.

[14]  J. Ahlner,et al.  Once daily dosing of enalapril in congestive heart failure. , 2009, Acta medica Scandinavica.

[15]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[16]  M. Packer,et al.  Comparison of captopril and enalapril in patients with severe chronic heart failure. , 1986, The New England journal of medicine.

[17]  P A Meredith,et al.  Pharmacodynamics and population pharmacokinetics of enalapril and lisinopril. , 1985, International journal of clinical pharmacology research.

[18]  K. Dickstein,et al.  Acute and long-term response to enalapril in congestive failure. , 1984, British journal of clinical pharmacology.